Direct Oral Anticoagulants and Bleeding Risk (in Comparison to Vitamin K Antagonists and Heparins), and the Treatment of BleedingPALARETI, Gualtiero.Seminars in hematology. 2014, Vol 51, Num 2, pp 102-111, issn 0037-1963, 10 p.Article

Perioperative Management Issues of Direct Oral AnticoagulantsKOZEK-LANGENECKER, Sibylle A.Seminars in hematology. 2014, Vol 51, Num 2, pp 112-120, issn 0037-1963, 9 p.Article

Direct Oral Anticoagulants in the Management of Venous Thromboembolism—Evidence From Major Clinical TrialsHOLY, Erik W; BEER, Jürg H.Seminars in hematology. 2014, Vol 51, Num 2, pp 131-138, issn 0037-1963, 8 p.Article

A 50-Year Journey to Cure Childhood Acute Lymphoblastic LeukemiaPUI, Ching-Hon; EVANS, William E.Seminars in hematology. 2013, Vol 50, Num 3, pp 185-196, issn 0037-1963, 12 p.Article

Aberrant Epigenetic Gene Regulation in Lymphoid Malignancies : Epigenetcis in HematologyTAYLOR, Kristen H; BRILEY, Aaron; ZHENG WANG et al.Seminars in hematology. 2013, Vol 50, Num 1, pp 38-47, issn 0037-1963, 10 p.Article

Hematologic Manifestations of Liver Disease : Consultative HematologyMARKS, Peter W.Seminars in hematology. 2013, Vol 50, Num 3, pp 216-221, issn 0037-1963, 6 p.Article

Newly Identified Mechanisms in B-Cell Non-Hodgkin Lymphomas Uncovered by Next-Generation Sequencing : Next-Generation Sequencing in Hematologic CancersMORIN, Ryan D; GASCOYNE, Randy D.Seminars in hematology. 2013, Vol 50, Num 4, pp 303-313, issn 0037-1963, 11 p.Article

Somatic Characterization of Pediatric Acute Myeloid Leukemia Using Next-Generation Sequencing : Next-Generation Sequencing in Hematologic CancersSCHUBACK, Heather L; ARCECI, Robert J; MESHINCHI, Soheil et al.Seminars in hematology. 2013, Vol 50, Num 4, pp 325-332, issn 0037-1963, 8 p.Article

Mouse Medicine and Human DiseaseYOUNG, Neal S.Seminars in hematology. 2013, Vol 50, Num 2, issn 0037-1963, 99 p.Serial Issue

Mouse Models in Bone Marrow Transplantation and Adoptive Cellular TherapyARBER, Caroline; BRENNER, Malcolm K; REDDY, Pavan et al.Seminars in hematology. 2013, Vol 50, Num 2, pp 131-144, issn 0037-1963, 14 p.Article

Endocrine Complications in Long-Term Survivors After Allogeneic Stem Cell TransplantGUNASEKARAN, Uma; AGARWAL, Neena; JAGASIA, Madan H et al.Seminars in hematology. 2012, Vol 49, Num 1, pp 66-72, issn 0037-1963, 7 p.Article

Eosinophilic Myeloid DisordersNOEL, Pierre.Seminars in hematology. 2012, Vol 49, Num 2, pp 120-127, issn 0037-1963, 8 p.Article

Biologic Impact of Proteasome Inhibition in Multiple Myeloma Cells—From the Aspects of Preclinical StudiesHIDESHIMA, Teru; ANDERSON, Kenneth C.Seminars in hematology. 2012, Vol 49, Num 3, pp 223-227, issn 0037-1963, 5 p.Article

Management Strategies for Relapsed/Refractory Multiple Myeloma: Current Clinical PerspectivesJAKUBOWIAK, Andrzej.Seminars in hematology. 2012, Vol 49, Num 3, issn 0037-1963, S16-S32, SUP1Article

Myelomagenesis: Capturing Early Microenvironment ChangesKORDE, Neha; MARIC, Irina.Seminars in hematology. 2011, Vol 48, Num 1, pp 13-21, issn 0037-1963, 9 p.Article

Diamond Blackfan Anemia and Ribosome BiogenesisEBERT, Benjamin; LIPTON, Jeffrey M.Seminars in hematology. 2011, Vol 48, Num 2, issn 0037-1963, 72 p.Serial Issue

Bendamustine: Rescue of an Effective Antineoplastic Agent From the Mid-Twentieth CenturyLEONI, Lorenzo M.Seminars in hematology. 2011, Vol 48, Num 2, issn 0037-1963, S4-S11, SUP1Article

Molecular Pathogenesis of Mantle Cell Lymphoma: New Perspectives and Challenges With Clinical ImplicationsNAVARRO, Alba; ROYO, Cristina; HERNANDEZ, Luis et al.Seminars in hematology. 2011, Vol 48, Num 3, pp 155-165, issn 0037-1963, 11 p.Article

Minimal Residual Disease Detection in Mantle Cell Lymphoma: Technical Aspects and Clinical RelevancePOTT, Christiane.Seminars in hematology. 2011, Vol 48, Num 3, pp 172-184, issn 0037-1963, 13 p.Article

Is There a Role for Watch and Wait in Patients With Mantle Cell Lymphoma?MARTIN, Peter; LEONARD, John.Seminars in hematology. 2011, Vol 48, Num 3, pp 189-193, issn 0037-1963, 5 p.Article

Treatment of Elderly Patients With Mantle Cell LymphomaKLUIN-NELEMANS, Hanneke C; DOORDUIJN, Jeanette K.Seminars in hematology. 2011, Vol 48, Num 3, pp 208-213, issn 0037-1963, 6 p.Article

CD20 as a Target for Therapeutic Type I and II Monoclonal AntibodiesBEERS, Stephen A; CHAN, Claude H. T; FRENCH, Ruth R et al.Seminars in hematology. 2010, Vol 47, Num 2, pp 107-114, issn 0037-1963, 8 p.Article

Status of Ongoing Collaborative EffortsVOSE, Julie M.Seminars in hematology. 2010, Vol 47, Num 2, issn 0037-1963, S18-S20, SUP1Article

Apoptotic Processes in Megakaryocytes and PlateletsWHITE, Michael J; KILE, Benjamin T.Seminars in hematology. 2010, Vol 47, Num 3, pp 227-234, issn 0037-1963, 8 p.Article

Biology and Chemistry of Thrombopoietic AgentsKUTER, David J.Seminars in hematology. 2010, Vol 47, Num 3, pp 243-248, issn 0037-1963, 6 p.Article